CoChat

Metformin directly targets the H3K27me3 demethylase KDM6A/UTX

Open access
Cuyàs, Elisabet, Verdura, Sara, Llorach‐Pares, Laura, Fernández‐Arroyo, Salvador, Luciano‐Mateo, Fedra, Cabré, Noemí, Stursa, Jan, Werner, Lukas, Martin‐Castillo, Begoña, Viollet, Benoit, Neuzil, Jiri, Joven, Jorge, Nonell‐Canals, Alfons, Sanchez‐Martinez, Melchor, Menendez, Javier A. · 2018 · Aging Cell
Cited by 79

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Summary: Metformin, the first drug chosen to be tested in a clinical trial aimed to target the biology of aging per se, has been clinically exploited for decades in the absence of a complete understanding of its therapeutic targets or chemical determinants. We here outline a systematic chemoinformatics approach to computationally predict biomolecular targets of metformin. Using several structure‐ and ligand‐based software tools and reference databases containing 1,300,000 chemical compounds and more than 9,000 binding sites protein cavities, we identified 41 putative metformin targets including several epigenetic modifiers such as the member of the H3K27me3‐specific demethylase subfamily, KDM6A/UTX. AlphaScreen and AlphaLISA assays confirmed the ability of metformin to inhibit the demethylation activity of purified KDM6A/UTX enzyme. Structural studies revealed that metformin might occupy the same set of residues involved in H3K27me3 binding and demethylation within the catalytic pocket of KDM6A/UTX. Millimolar metformin augmented global levels of H3K27me3 in cultured cells, including reversion of global loss of H3K27me3 occurring in premature aging syndromes, irrespective of mitochondrial complex I or AMPK. Pharmacological doses of metformin in drinking water or intraperitoneal injection significantly elevated the global levels of H3K27me3 in the hepatic tissue of low‐density lipoprotein receptor‐deficient mice and in the tumor tissues of highly aggressive breast cancer xenograft‐bearing mice. Moreover, nondiabetic breast cancer patients receiving oral metformin in addition to standard therapy presented an elevated level of circulating H3K27me3. Our biocomputational approach coupled to experimental validation reveals that metformin might directly regulate the biological machinery of aging by targeting core chromatin modifiers of the epigenome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/acel.12772

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 79

Metadata

Authors
Cuyàs, E., Verdura, S., Llorach‐Pares, L., Fernández‐Arroyo, S., Luciano‐Mateo, F., Cabré, N., Stursa, J., Werner, L., Martin‐Castillo, B., Viollet, B., Neuzil, J., Joven, J., Nonell‐Canals, A., Sanchez‐Martinez, M., & Menendez, J. A.
Venue
Aging Cell
Publisher
Wiley
Published
2018-05-08
Volume
17
Issue
4
Pages
e12772-e12772
ISSN
  • 1474-9718 (ISSN-L)
  • 1474-9726
OpenAlex
W2801977840
Cited by
79
References
19
FWCI
3.22
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin directly targets the H3K27me3 demethylase KDM6A/UTX. https://app.cochat.ai/papers/10.1111/acel.12772
The paper
Cuyàs, E., Verdura, S., Llorach‐Pares, L., Fernández‐Arroyo, S., Luciano‐Mateo, F., Cabré, N., Stursa, J., Werner, L., Martin‐Castillo, B., Viollet, B., Neuzil, J., Joven, J., Nonell‐Canals, A., Sanchez‐Martinez, M., & Menendez, J. A. (2018). Metformin directly targets the H3K27me3 demethylase KDM6A/UTX. Aging Cell. https://doi.org/10.1111/acel.12772

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.